SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-204493
Filing Date
2013-05-07
Accepted
2013-05-07 16:21:58
Documents
3
Period of Report
2013-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d533560d8k.htm 8-K 24961
2 EX-99.1 d533560dex991.htm EX-99.1 187493
3 GRAPHIC g533560004.jpg GRAPHIC 4884
  Complete submission text file 0001193125-13-204493.txt   220782
Mailing Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4
Business Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4 353-1-634-4183
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 13820293
SIC: 2834 Pharmaceutical Preparations